Oleksandr Sverdlov
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Statistical Methods in Clinical Trials, Advanced Causal Inference Techniques, Optimal Experimental Design Methods, Health Systems, Economic Evaluations, Quality of Life, Statistical Methods and Bayesian Inference
Most-Cited Works
- → Handling Covariates in the Design of Clinical Trials(2008)180 cited
- → Digital Therapeutics: An Integral Component of Digital Innovation in Drug Development(2018)147 cited
- → A roadmap to using randomization in clinical trials(2021)116 cited
- → Adaptive Randomization for Clinical Trials(2012)91 cited
- → Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study of the Oral γ-Secretase Inhibitor BMS-708163 (Avagacestat): Tolerability Profile, Pharmacokinetic Parameters, and Pharmacodynamic Markers(2012)65 cited
- → Pharmacodynamics of Selective Inhibition of γ-Secretase by Avagacestat(2012)63 cited
- → A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects(2012)47 cited
- → Optimal response‐adaptive randomized designs for multi‐armed survival trials(2011)43 cited
- → A Study of Novel Exploratory Tools, Digital Technologies, and Central Nervous System Biomarkers to Characterize Unipolar Depression(2021)41 cited
- → On Recent Advances in Optimal Allocation Designs in Clinical Trials(2013)35 cited